Leaflet BERINERT 500 500UI powder and solvent for solution for injection / infusion

Product code:
W58531001
Quantity:
1
Indicated for:
hereditary angioedema
Route of administration:
injectable / infusion
Substance:
human C1 esterase inhibitor (C1 esterase inhibitor)
ATC
B06AC01 — Blood and blood forming organs | Other hematological agents | Other hematological agents | Drugs used in hereditary angioedema
Human C1 esterase inhibitor is used for the treatment of hereditary angioedema, a genetic condition characterized by recurrent episodes of severe swelling. It works by regulating the activity of the complement system and preventing its excessive activation.

The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for adverse reactions during the infusion.

Side effects may include headache, nausea, dizziness, or injection site reactions. In rare cases, severe allergic reactions may occur.

This medication is not recommended for patients with hypersensitivity to human plasma proteins or severe IgA deficiency.

General data about BERINERT 500 500UI

Substance:
human C1 esterase inhibitor
Date of latest medicines list:
01-06-2026
Product code:
W58531001
Concentration:
500UI
Pharmaceutical form:
powder and solvent for solution for injection / infusion
Quantity:
1
Product type:
Original
Price:
2579.96 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
CSL BEHRING GMBH - GERMANIA
Holder:
CSL BEHRING GMBH - GERMANIA
Number:
7182/2014/01
Shelf life:
30 months

Concentrations available for human C1 esterase inhibitor

  • 1500UI
  • 2000UI
  • 3000UI
  • 500 U
  • 500UI

Compensation lists for BERINERT 500 500UI CSL Behring

NHP 6.22 (C2) - Hereditary angioedema

Price
2579.96 RON
Copayment
2579.96 RON
Patient
0.00 RON